| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Departments of Biology [D. C. Q.], Pathology [H. M. D.], and Surgery [D. C. Q., A. G. D., C. L. S., H. E. W.], West Virginia University, Morgantown, West Virginia 26506
Mutations in the gene coding for the p53 tumor suppressor protein are common in a variety of human cancers. To assess the role of a putative mutated p53 protein in human lung cancer, a monoclonal antibody recognizing it was used in an immunoperoxidase detection system. A total of 114 cases of Stage I and II adenocarcinomas and squamous cell carcinomas were studied. The staining pattern was always intranuclear and heterogeneous. When the median or mean survival time was compared between cases, p53 accumulation had a statistically significant negative prognostic value. This was supported by a Kaplan-Meier survival plot of p53 producers and nonproducers. In 7 of 24 Stage II cases that were negative for p53 in the primary tumor, metastatic regional lymph nodes were p53-positive. These latter cases had greatly reduced survival times. Thus, p53 accumulation in primary tumors (and regional lymph nodes) may identify a subgroup of lung cancer patients with a prognosis of more aggressive disease.
1 To whom requests for reprints should be addressed, at Department of Biology, West Virginia University, Morgantown, West Virginia 26506-6057.
Received 6/12/92. Accepted 7/24/92.
This article has been cited by other articles:
|
|
 |
|
  Q. Cheng, X. Luo, B. Zhang, X. Jiang, B. Yi, and M. Wu Distal Bile Duct Carcinoma: Prognostic Factors After Curative Surgery. A Series of 112 Cases Ann. Surg. Oncol., March 1, 2007; 14(3): 1212 - 1219. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Tsubochi, N. Sato, M. Hiyama, M. Kaimori, S. Endo, Y. Sohara, and T. Imai Combined Analysis of Cyclooxygenase-2 Expression With p53 and Ki-67 in Nonsmall Cell Lung Cancer. Ann. Thorac. Surg., October 1, 2006; 82(4): 1198 - 1204. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Singhal, A. Vachani, D. Antin-Ozerkis, L. R. Kaiser, and S. M. Albelda Prognostic Implications of Cell Cycle, Apoptosis, and Angiogenesis Biomarkers in Non-Small Cell Lung Cancer: A Review Clin. Cancer Res., June 1, 2005; 11(11): 3974 - 3986. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D Santini, G Tonini, F M Vecchio, D Borzomati, B Vincenzi, S Valeri, A Antinori, F Castri, R Coppola, P Magistrelli, et al. Prognostic value of Bax, Bcl-2, p53, and TUNEL staining in patients with radically resected ampullary carcinoma J. Clin. Pathol., February 1, 2005; 58(2): 159 - 165. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Havrilesky, K. M. Darcy, H. Hamdan, R. L. Priore, J. Leon, J. Bell, and A. Berchuck Prognostic Significance of p53 Mutation and p53 Overexpression in Advanced Epithelial Ovarian Cancer: A Gynecologic Oncology Group Study J. Clin. Oncol., October 15, 2003; 21(20): 3814 - 3825. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J Shaham, Y Bomstein, R Gurvich, M Rashkovsky, and Z Kaufman DNA-protein crosslinks and p53 protein expression in relation to occupational exposure to formaldehyde Occup. Environ. Med., June 1, 2003; 60(6): 403 - 409. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y.-L. Cheng, S.-C. Lee, H.-J. Harn, C.-J. Chen, Y.-C. Chang, J.-C. Chen, and C.-P. Yu Prognostic prediction of the immunohistochemical expression of p53 and p16 in resected non-small cell lung cancer Eur. J. Cardiothorac. Surg., February 1, 2003; 23(2): 221 - 228. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. G. Swisher, J. A. Roth, R. Komaki, J. Gu, J. J. Lee, M. Hicks, J. Y. Ro, W. K. Hong, J. A. Merritt, K. Ahrar, et al. Induction of p53-regulated Genes and Tumor Regression in Lung Cancer Patients after Intratumoral Delivery of Adenoviral p53 (INGN 201) and Radiation Therapy Clin. Cancer Res., January 1, 2003; 9(1): 93 - 101. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. D. Brundage, D. Davies, and W. J. Mackillop Prognostic Factors in Non-small Cell Lung Cancer* : A Decade of Progress Chest, September 1, 2002; 122(3): 1037 - 1057. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. K. Dy and A. A. Adjei Novel Targets for Lung Cancer Therapy: Part II J. Clin. Oncol., July 1, 2002; 20(13): 3016 - 3028. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Marchetti, N. Tinari, F. Buttitta, A. Chella, C. A. Angeletti, R. Sacco, F. Mucilli, A. Ullrich, and S. Iacobelli Expression of 90K (Mac-2 BP) Correlates with Distant Metastasis and Predicts Survival in Stage I Non-Small Cell Lung Cancer Patients Cancer Res., May 1, 2002; 62(9): 2535 - 2539. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Steels, M. Paesmans, T. Berghmans, F. Branle, F. Lemaitre, C. Mascaux, A.P. Meert, F. Vallot, J.J. Lafitte, and J.P. Sculier Role of p53 as a prognostic factor for survival in lung cancer: a systematic review of the literature with a meta-analysis Eur. Respir. J., October 1, 2001; 18(4): 705 - 719. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Soini, K. Kahlos, U. Napankangas, R. Kaarteenaho-Wiik, M. Saily, P. Koistinen, P. Paaakko, A. Holmgren, and V. L. Kinnula Widespread Expression of Thioredoxin and Thioredoxin Reductase in Non-Small Cell Lung Carcinoma Clin. Cancer Res., June 1, 2001; 7(6): 1750 - 1757. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Laudanski, W. Niklinska, T. Burzykowski, L. Chyczewski, and J. Niklinski Prognostic significance of p53 and bcl-2 abnormalities in operable non-small cell lung cancer Eur. Respir. J., April 1, 2001; 17(4): 660 - 666. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Schuler, R. Herrmann, J. L.P. De Greve, A. K. Stewart, U. Gatzemeier, D. J. Stewart, L. Laufman, R. Gralla, J. Kuball, R. Buhl, et al. Adenovirus-Mediated Wild-Type p53 Gene Transfer in Patients Receiving Chemotherapy for Advanced Non-Small-Cell Lung Cancer: Results of a Multicenter Phase II Study J. Clin. Oncol., March 15, 2001; 19(6): 1750 - 1758. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. H. Schiller, S. Adak, R. H. Feins, S. M. Keller, W. A. Fry, R. B. Livingston, M. E. M. Hammond, B. Wolf, L. Sabatini, J. Jett, et al. Lack of Prognostic Significance of p53 and K-ras Mutations in Primary Resected Non-Small-Cell Lung Cancer on E4592: A Laboratory Ancillary Study on an Eastern Cooperative Oncology Group Prospective Randomized Trial of Postoperative Adjuvant Therapy J. Clin. Oncol., January 15, 2001; 19(2): 448 - 457. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Mitsudomi, N. Hamajima, M. Ogawa, and T. Takahashi Prognostic Significance of p53 Alterations in Patients with Non-Small Cell Lung Cancer: A Meta-Analysis Clin. Cancer Res., October 1, 2000; 6(10): 4055 - 4063. [Abstract] [Full Text]
|
|
|
|
|
|
Y. Ohmura, M. Aoe, A. Andou, and N. Shimizu Telomerase Activity and Bcl-2 Expression in Non-Small Cell Lung Cancer Clin. Cancer Res., August 1, 2000; 6(8): 2980 - 2987. [Abstract] [Full Text]
|
|
|
|
|
|
J. Nemunaitis, S. G. Swisher, T. Timmons, D. Connors, M. Mack, L. Doerksen, D. Weill, J. Wait, D. D. Lawrence, B. L. Kemp, et al. Adenovirus-Mediated p53 Gene Transfer in Sequence With Cisplatin to Tumors of Patients With Non-Small-Cell Lung Cancer J. Clin. Oncol., February 1, 2000; 18(3): 609 - 609. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Murakami, K. Hiyama, S. Ishioka, M. Yamakido, F. Kasagi, and Y. Yokosaki p53 Gene Mutations Are Associated with Shortened Survival in Patients with Advanced Non-small Cell Lung Cancer: An Analysis of Medically Managed Patients Clin. Cancer Res., February 1, 2000; 6(2): 526 - 530. [Abstract] [Full Text]
|
|
|
|
|
|
M. J. Krasna, Y. S. Mao, J. R. Sonett, G. Tamura, R. Jones, M. Suntharalingam, and S. J. Meltzer P53 gene protein overexpression predicts results of trimodality therapy in esophageal cancer patients Ann. Thorac. Surg., December 1, 1999; 68(6): 2021 - 2024. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Hashimoto, Y. Tokuchi, M. Hayashi, Y. Kobayashi, K. Nishida, S.-i. Hayashi, Y. Ishikawa, S. Tsuchiya, K. Nakagawa, J.-i. Hayashi, et al. p53 Null Mutations Undetected by Immunohistochemical Staining Predict a Poor Outcome with Early-Stage Non-Small Cell Lung Carcinomas Cancer Res., November 1, 1999; 59(21): 5572 - 5577. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y.-C. Lee, Y.-L. Chang, S.-P. Luh, J.-M. Lee, and J.-S. Chen Significance of P53 and Rb protein expression in surgically treated non-small cell lung cancers Ann. Thorac. Surg., August 1, 1999; 68(2): 343 - 347. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A.-M. C. Dingemans, M. A. Witlox, R. A. L. M. Stallaert, P. van der Valk, P. E. Postmus, and G. Giaccone Expression of DNA Topoisomerase II{{alpha}} and Topoisomerase II{beta} Genes Predicts Survival and Response to Chemotherapy in Patients with Small Cell Lung Cancer Clin. Cancer Res., August 1, 1999; 5(8): 2048 - 2058. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. C. Tammemagi, J. R. McLaughlin, and S. B. Bull Meta-Analyses of p53 Tumor Suppressor Gene Alterations and Clinicopathological Features in Resected Lung Cancers Cancer Epidemiol. Biomarkers Prev., July 1, 1999; 8(7): 625 - 634. [Abstract] [Full Text]
|
|
|
|
|
|
F. Tanaka, R. Miyahara, Y. Ohtake, K. Yanagihara, T. Fukuse, S. Hitomi, and H. Wada Lewis Y antigen expression and postoperative survival in non-small cell lung cancer Ann. Thorac. Surg., November 1, 1998; 66(5): 1745 - 1750. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Perz and J. G. Kuhn Review : p53 in the pathogenesis, diagnosis, and treatment of cancer Journal of Oncology Pharmacy Practice, June 1, 1998; 4(2): 75 - 102. [Abstract] [PDF]
|
|
|
|
 |
|
 I. Cordone, S. Masi, F. R. Mauro, S. Soddu, O. Morsilli, T. Valentini, M. L. Vegna, C. Guglielmi, F. Mancini, S. Giuliacci, et al. p53 Expression in B-Cell Chronic Lymphocytic Leukemia: A Marker of Disease Progression and Poor Prognosis Blood, June 1, 1998; 91(11): 4342 - 4349. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. M. GREATENS, G. A. NIEHANS, J. B. RUBINS, J. JESSURUN, R. A. KRATZKE, M. A. MADDAUS, and D. E. NIEWOEHNER Do Molecular Markers Predict Survival in Non-Small-Cell Lung Cancer? Am. J. Respir. Crit. Care Med., April 1, 1998; 157(4): 1093 - 1097. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. C. Nesbitt, J. B. Putnam Jr, G. L. Walsh, J. A. Roth, and C. F. Mountain Survival in Early-Stage Non--Small Cell Lung Cancer Ann. Thorac. Surg., August 1, 1995; 60(2): 466 - 472. [Abstract] [Full Text]
|
|
|
|
 |
|
 B. Passlick, J. R. Izbicki, K. Haussinger, O. Thetter, and K. Pantel Immunohistochemical detection of p53 protein is not associated with a poor prognosis in non-small-cell lung cancer J. Thorac. Cardiovasc. Surg., June 1, 1995; 109(6): 1205 - 1211. [Abstract] [Full Text]
|
|
|
|
 |
|
 H. P. Rutz, R. O. Mirimanoff, C. Bokemeyer, M. A. Kuczyk, J. Sehrt, M. Muller, M. Volkmann, H. Zentgraf, and P. R. Galle Clinical Implications of the p53 Tumor-Suppressor Gene N. Engl. J. Med., March 24, 1994; 330(12): 864 - 865. [Full Text]
|
|
|
|
|
|
P. F. Bongiorno, R. I. Whyte, E. J. Lesser, J. H. Moore, M. B. Orringer, and D. G. Beer Alterations of K-ras, p53, and erbB-2/neu in human lung adenocarcinomas J. Thorac. Cardiovasc. Surg., February 1, 1994; 107(2): 590 - 595. [Abstract] [Full Text]
|
|
|
|
|
|
C. C. Harris and M. Hollstein Clinical Implications of the p53 Tumor-Suppressor Gene N. Engl. J. Med., October 28, 1993; 329(18): 1318 - 1327. [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
